Menu Search
Equities

Farmacias Benavides SAB de CV

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BEVIDESB:MEX

Farmacias Benavides SAB de CV

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (MXN)26.00
  • Today's Change0.00 / 0.00%
  • Shares traded10.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Oct 29 2025 19:16 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in MXNIncome statement in MXNView more

Year on year Farmacias Benavides SAB de CV's net income fell -53.77% from 282.33m to 130.52m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 25.80% to 26.66%.
Gross margin31.08%
Net profit margin1.24%
Operating margin5.08%
Return on assets2.65%
Return on equity29.98%
Return on investment6.38%
More ▼

Cash flow in MXNView more

In 2024, cash reserves at Farmacias Benavides SAB de CV fell by 310.58m. However, the company earned 586.59m from its operations for a Cash Flow Margin of 3.32%. In addition the company used 138.61m on investing activities and also paid 758.56m in financing cash flows.
Cash flow per share3.11
Price/Cash flow per share7.31
Book value per share2.16
Tangible book value per share2.09
More ▼

Balance sheet in MXNView more

Farmacias Benavides SAB de CV has a Debt to Total Capital ratio of 74.63%, a lower figure than the previous year's 318.95%.
Current ratio0.8971
Quick ratio0.3233
Total debt/total equity2.94
Total debt/total capital0.7463
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.